Health Condition 1: - Health Condition 2: O- Medical and Surgical Health Condition 3: O- Medical and Surgical
Conditions
Interventions
Intervention1: Intra vitreal Anti VEGF:
: Under aseptic precautions, patients eye will be draped, injection site marked with dye (4 mm distance from limbus in phakics and 3.5 mm distance from limbus
Sponsors
SANKARA EYE HOSPITAL
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with Treatment naïve proliferative diabetic retinopathy (NVE/NVD) 2.Willing to undergo PRP/Anti VEGF injections Â
Exclusion criteria
Exclusion criteria: 1.Other causes of neovascularisation (Retinal vein occlusion, fibrovascular proliferation with retinal traction, fibrosis, scarring, atrophy) 2.Diabetic Macular Edema 3.Vitreous hemorrhage which obscures imaging 4.Uncontrolled glaucoma 5.Outside OCTA scan range 6.Previous history of optic neuropathy 7.Poor quality scans(media opacity)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in area of neovascularization on OCT AngiographyTimepoint: 1. PRP group: Baseline,at 1st PRP, at 1 week, at 2 weeks, at 3 weeks, at 1 month and at 3 months 2. Anti VEGF group: Baseline, at 1st injection, at 1 month, at 2 months, at 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Observation of complications related to therapy Timepoint: 1. PRP group: 1 week post PRP,2 weeks post PRP, 3 weeks post PRP, at 1 month and at 3 months 2. Anti VEGF Group: post injection at 1 month, at 2 months and at 3 months | — |
Countries
India
Contacts
Public ContactDr PATIL RUTUJA SADASHIV
SANKARA EYE HOSPITAL GUNTUR
Outcome results
None listed